Literature DB >> 16680111

TeGenero fiasco prompts regulatory rethink.

Cormac Sheridan.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16680111     DOI: 10.1038/nbt0506-475

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  11 in total

1.  The structural and energetic basis for high selectivity in a high-affinity protein-protein interaction.

Authors:  Nicola A G Meenan; Amit Sharma; Sarel J Fleishman; Colin J Macdonald; Bertrand Morel; Ruth Boetzel; Geoffrey R Moore; David Baker; Colin Kleanthous
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 2.  Are BiTEs the "missing link" in cancer therapy?

Authors:  Carter M Suryadevara; Patrick C Gedeon; Luis Sanchez-Perez; Terence Verla; Christopher Alvarez-Breckenridge; Bryan D Choi; Peter E Fecci; John H Sampson
Journal:  Oncoimmunology       Date:  2015-04-30       Impact factor: 8.110

3.  Industry pursues co-stimulatory receptor immunomodulators to treat cancer.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

4.  Twitter storm forces Chimerix's hand in compassionate use request.

Authors:  Michael Goodman
Journal:  Nat Biotechnol       Date:  2014-06       Impact factor: 54.908

5.  Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.

Authors:  Vijayakumar Velu; Sunil Kannanganat; Chris Ibegbu; Lakshmi Chennareddi; Francois Villinger; Gordon J Freeman; Rafi Ahmed; Rama Rao Amara
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 6.  Risks of phase I research with healthy participants: A systematic review.

Authors:  Rebecca A Johnson; Annette Rid; Ezekiel Emanuel; David Wendler
Journal:  Clin Trials       Date:  2015-09-08       Impact factor: 2.486

Review 7.  [Drug trials in humans. Risks in the light of the London catastrophe].

Authors:  A Otte
Journal:  Internist (Berl)       Date:  2007-06       Impact factor: 0.743

8.  Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection.

Authors:  Nattawat Onlamoon; Kenneth Rogers; Ann E Mayne; Kovit Pattanapanyasat; Kazuyasu Mori; Francois Villinger; Aftab A Ansari
Journal:  Immunology       Date:  2008-02-05       Impact factor: 7.397

9.  Manipulation of the complement system for benefit in sepsis.

Authors:  Peter A Ward; Ren-Feng Guo; Niels C Riedemann
Journal:  Crit Care Res Pract       Date:  2012-03-05

Review 10.  What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of: "all that is necessary for the triumph of evil is that good men do nothing"?

Authors:  Chris R Triggle; David J Triggle
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.